| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/19/2014 | CN102503953B Oximes compound |
| 02/19/2014 | CN102452951B Agomelatine and pharmaceutical composition thereof |
| 02/19/2014 | CN102372659B Indolebenzamide derivatives and medicinal applications thereof |
| 02/19/2014 | CN102356061B Method for producing bicyclic g-amino acid derivative |
| 02/19/2014 | CN102311448B Thieno-pyrimidone DPP-IV (dipeptidyl peptidase) inhibitor |
| 02/19/2014 | CN102210759B Application of Chinese medicinal component in preparation of nitric oxide donor medicament |
| 02/19/2014 | CN102048717B Stable rasagiline composition |
| 02/19/2014 | CN101827836B Trisubstituted 1,2,4-triazoles |
| 02/18/2014 | US8653257 Dibenzothiazepine derivatives and uses thereof—424 |
| 02/18/2014 | US8653122 Oromucosal formulation and process for preparing the same |
| 02/18/2014 | US8653119 Methods for treating transthyretin amyloid diseases |
| 02/18/2014 | US8653107 Fentanyl composition for nasal administration |
| 02/18/2014 | US8653104 PTEN inhibitor or Maxi-K channels opener |
| 02/18/2014 | US8653092 Tetrahydro-pyrido-pyrimidine derivatives |
| 02/18/2014 | US8653091 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| 02/18/2014 | US8653088 Compositions useful as inhibitors of protein kinases |
| 02/18/2014 | US8653077 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 02/18/2014 | US8653050 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
| 02/18/2014 | US8653033 Method for administering omega-conopeptide |
| 02/18/2014 | US8653032 Pharmaceutical composition for preventing / treating TRPV1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient |
| 02/18/2014 | US8653023 Dual beneficial effect of dopamine enhancing and neuroprotective actions of PKC delta inhibitors for treatment of Parkinson's disease |
| 02/18/2014 | US8652517 Coating of tablet cores |
| 02/18/2014 | CA2744857C Cyclobutyl purine derivative, angiogenesis promoting agent, lumen formation promoting agent, neurocyte growth promoting agent, and drug |
| 02/18/2014 | CA2701594C Heterocycle phenyl amide t-type calcium channel antagonists |
| 02/18/2014 | CA2698172C Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties |
| 02/18/2014 | CA2624492C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 02/18/2014 | CA2623250C Fluorinated compounds |
| 02/18/2014 | CA2600757C Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 02/18/2014 | CA2577061C Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/18/2014 | CA2548310C Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| 02/18/2014 | CA2472203C The use of il6r/il6 chimera in nerve cell regeneration |
| 02/18/2014 | CA2331923C Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 02/13/2014 | WO2014026164A1 Compositions for preventing or slowing myelin deterioration or loss and for promoting myelin repair and method of making and using the same |
| 02/13/2014 | WO2014026121A1 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 02/13/2014 | WO2014025993A1 Inhibitors of d-amino acid oxidase |
| 02/13/2014 | WO2014025942A1 Nmda receptor modulators and uses related thereto |
| 02/13/2014 | WO2014025905A1 Multi-component formulation for improving neurological function |
| 02/13/2014 | WO2014025837A1 Methods for treatment and prevention of tauopathies by inhibiting endothelin receptors |
| 02/13/2014 | WO2014025808A1 Curcumin analogs |
| 02/13/2014 | WO2014025761A1 Methods to treat neurodegenerative diseases |
| 02/13/2014 | WO2014025679A1 Process for the preparation of c-fms kinase inhibitors |
| 02/13/2014 | WO2014025651A1 Chroman derivatives as trpm8 inhibitors |
| 02/13/2014 | WO2014025202A1 Pharmaceutical composition comprising mixed extract of zingiber officinale rosc, and paeonia lactiflora pallas for preventing or treating dementia and cognitive dysfunction |
| 02/13/2014 | WO2014025019A1 Animal feed and stress reducer for industrial animals |
| 02/13/2014 | WO2014024993A1 Piperazine derivative and use thereof |
| 02/13/2014 | WO2014024984A1 Hydrogen mixed gas supply device for medical purposes |
| 02/13/2014 | WO2014024125A1 Pyrazolo[4,3-d]pyrimidin-7(6h)-one derivatives as pde9 inhibitors |
| 02/13/2014 | WO2014023860A1 Compositions comprising plasma growth factors for use in the treatment of neurodegenerative disorders |
| 02/13/2014 | WO2014023674A1 Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one |
| 02/13/2014 | WO2014023390A2 (aza-)isoquinolinone derivatives |
| 02/13/2014 | WO2014023385A1 Pyridopyrimidine derivatives as protein kinase inhibitors |
| 02/13/2014 | WO2014023191A1 N-substituted pyrazolo [3, 4-d] pyrimidine ketone compound and preparation method and application thereof |
| 02/13/2014 | WO2014023129A1 α-CONOTOXIN PEPTIDE, AND MEDICAL COMPOSITION AND PURPOSE THEREOF |
| 02/13/2014 | WO2014022879A1 Compounds for the treatment of mtor pathway related diseases |
| 02/13/2014 | WO2013102195A8 Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives |
| 02/13/2014 | US20140047569 Methods of Treating Disorders Associated with Protein Aggregation |
| 02/13/2014 | US20140046287 Microfabricated nanopore device for sustained release of therapeutic agent |
| 02/13/2014 | US20140045932 Flavanol and carotenoid compositions |
| 02/13/2014 | US20140045907 Use of Inhibitors of the Renin-Angiotensin System |
| 02/13/2014 | US20140045885 Decoquinate, 4-hydroxyquinolones and napthoquinones combined with levamisole, Imidazothiazole, for the prevention and treatment of sarcocystosis and equine protozoal myeloencephalitis caused by Sarcocystis and Neospora and other apicomplexan protozoans. |
| 02/13/2014 | US20140045880 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 02/13/2014 | US20140045878 Matrix for sustained, invariant and independent release of active compounds |
| 02/13/2014 | US20140045877 Pharmaceutical preparation containing oxycodone and naloxone |
| 02/13/2014 | US20140045801 Pramipexole transdermal delivery for severe headaches |
| 02/13/2014 | US20140045749 Growth factor complex |
| 02/13/2014 | US20140044816 Spray method and composition for reducing substance craving |
| 02/13/2014 | US20140044753 Composition containing inorganic nanoparticles as an active ingredient for preventing or treating of angiogenesis-related diseases |
| 02/13/2014 | US20140044725 Alzheimer's disease treatment method |
| 02/12/2014 | EP2695883A2 Tricyclic derivatives of n,n'-substituted 3,7-diazabicyclo [3.3.1]nonanes and drugs based thereon |
| 02/12/2014 | EP2695618A1 Pharmaceutical composition with synergistic anticonvulsant effect |
| 02/12/2014 | EP2694540A2 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists |
| 02/12/2014 | EP2694521A1 Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| 02/12/2014 | EP2694509A1 Pyrrolo [2, 3 -d]pyrimidine derivatives as inhibitors of tropomyosin- related kinases |
| 02/12/2014 | EP2694504A2 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer |
| 02/12/2014 | EP2694496A1 3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pain, cancer and respiratory, allergic, nervous system or cardiovascular disorders |
| 02/12/2014 | EP2694495A1 1,4-oxazepines as bace1 and/or bace2 inhibitors |
| 02/12/2014 | EP2694492A1 Novel compounds as histamine h3 receptor ligands |
| 02/12/2014 | EP2694474A1 4r,5r-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity |
| 02/12/2014 | EP2694472A2 Sulfonamide derivative and use thereof |
| 02/12/2014 | EP2694061A2 Compounds for use as therapeutic agents affecting p53 expression and/or activity |
| 02/12/2014 | EP2694057A1 Lipoxygenase inhibitors |
| 02/12/2014 | EP2694051A1 Use of l-carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function |
| 02/12/2014 | EP2694050A1 Tapentadol for treating pain associated with trigeminal neuralgia |
| 02/12/2014 | EP2694049A1 Tapentadol for preventing chronification of pain |
| 02/12/2014 | EP2694043A1 Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder |
| 02/12/2014 | EP2693894A2 Means for concealing the flavour and smell of peptide hydrolysates |
| 02/12/2014 | CN103582629A 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/2-pyrimidine-carborxamides as MGLUR5 modulators |
| 02/12/2014 | CN103582495A Psychic energizer agent and psychic energizer composition |
| 02/12/2014 | CN103582490A Hepatocyte growth factor mimics as therapeutic agents |
| 02/12/2014 | CN103570834A Methoxy polyethylene glycol-modified erythropoietin mimic peptide derivative |
| 02/12/2014 | CN103570808A Alpha-conotoxin peptide TxIB/Txd4, as well as pharmaceutical composition and use thereof |
| 02/12/2014 | CN103570806A 多肽环氧酮化合物 Peptide epoxy ketone compound |
| 02/12/2014 | CN103570730A Condensed ring pyridazinone compound with bridge ring structure as well as preparation method and application thereof |
| 02/12/2014 | CN103570726A N-alkyl tryptanthrin derivative, as well as preparation method and application thereof |
| 02/12/2014 | CN103570725A Piperazidinoltriazole compound as well as preparation method and application thereof |
| 02/12/2014 | CN103570722A Fused ring pyridazinone compounds, preparation method and uses thereof |
| 02/12/2014 | CN103570715A Salt of uncaria alkaloid derivative |
| 02/12/2014 | CN103570709A Pyrazolopyridine compounds, preparation method, uses and drug composition thereof |
| 02/12/2014 | CN103570669A Brain-targeted O-desmethylvenlafaxine phenolic ester prodrug and preparation method and applications thereof |
| 02/12/2014 | CN103570630A Heterocyclic nitrogen derivative and application thereof in medicines |